CareLit · DOI-Nachweis · Klinische Pädiatrie
Sensitivity of primary Glioblastoma cell lines towards Cilengitide alone and in combination with Temozolomide
DOI 10.1055/s-0032-1320182
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Schubert, C Mullins, J Piek, CF Classen
ZeitschriftKlinische Pädiatrie
Ausgabe11/2012
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Glioblastoma multiforma (GBM) still has a very poor prognosis even with today's aggressive combination therapy of resection followed by radio-chemotherapy with Temozolomide. It is mainly characterized by an enormous high level of tumor vascularization and infiltrative growth.In both these processes, integrins play an important role as transmembrane heterodimeric glycoproteins mediating the interaction between cells…
Zitieren
Zitierempfehlung
J Schubert, C Mullins, J Piek, CF Classen (2012) Sensitivity of primary Glioblastoma cell lines towards Cilengitide alone and in combination with Temozolomide. Klinische Pädiatrie (11). https://doi.org/10.1055/s-0032-1320182
Mit CareLit weiterarbeiten